If youre curious whether GLP-1 microdosing is right for you, or if youve tried them before and felt overwhelmed, youre not alone
(21) After 52 weeks, there was no significant difference in P1NP between semaglutide and placebo groups, with an estimated difference of 3.8 g/L (95% CI: 5.6-13.3, p = 0.418)
Higher doses are more likely to cause these symptoms, which is why starting low and going slow is so important
This article is about making GLP-1 therapy work better not about avoiding it
For substance-use disorders, early evidence suggested that GLP-1RAs might reduce alcohol and opioid cravings by influencing dopamine pathways involved in reward processing
A simple strategy: at every meal, eat your protein source first, before anything else